Next Quarterly Earnings
Wednesday, November 18, 2026
CW 47
After-Hours
In 83 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ArriVent Biopharma
ArriVent Biopharma, based in the USA, is an innovative biopharmaceutical company specializing in the development of novel cancer therapies. Through strategic partnerships, ArriVent identifies and transforms promising drug candidates for the treatment of solid tumors.
Frequently asked questions
When will ArriVent Biopharma report its next quarterly earnings?
ArriVent Biopharma is scheduled to report its next quarterly earnings on 11/18/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did ArriVent Biopharma last report quarterly earnings?
ArriVent Biopharma last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -1.05 USD.
How does ArriVent Biopharma stock react to earnings?
Across its last 3 earnings reports, ArriVent Biopharma stock moved by ±4% on average the following day. The largest reaction was -7.2% on 03/05/2026; 0 of 3 reactions were positive.
How often has ArriVent Biopharma beaten expectations?
ArriVent Biopharma has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
How do I add the ArriVent Biopharma earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±4%
Avg. next-day move
-7.2%
Largest move (03/05/2026)
0%
Share of positive reactions
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
1/5
Quarters above estimates
20%
Beat rate
-2.7%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
ArriVent Biopharma
Country
🇺🇸
More Financial Information